One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Editorial introductions.
doi : 10.1097/BOR.0000000000001010
Volume 36(3) pgs. v-v,155-250 May 2024
Management of postinfectious inflammatory arthritis.
Baker, Hailey a; Amaral, J. Kennedy b; Schoen, Robert T. a
Sodium-glucose cotransporter 2 inhibitors: are they ready for prime time in the management of lupus nephritis?.
Wagner, Benjamin R.; Rao, Panduranga S.
Emerging biologic therapies for systemic lupus erythematosus.
Kato, Hiroshi; Kahlenberg, J. Michelle
Chimeric antigen receptors: "CARs" in the fast lane for rheumatology.
Johnson, Nathan M.; Koumpouras, Fotios
Safety of biologic agents for the management of rheumatic diseases during pregnancy.
D'Gama, Jonathan D.; Bermas, Bonnie L.
Monogenic lupus: insights into disease pathogenesis and therapeutic opportunities.
Qin, Yuting a; Ma, Jianyang a; Vinuesa, Carola G. a,b
Rheumatoid arthritis - the challenge of heterogeneity.
Fox, David A.
Updates on interstitial lung disease and other selected extra-articular manifestations of rheumatoid arthritis.
Myasoedova, Elena; Matteson, Eric L.
Cardiovascular complications of rheumatoid arthritis.
Park, Elizabeth; Bathon, Joan
Autoantibodies in rheumatoid arthritis - rheumatoid factor, anticitrullinated protein antibodies and beyond .
Steiner, Gunter a,b; Toes, Rene E.M. c
Rheumatoid arthritis: prediction of future clinically-apparent disease, and prevention.
Deane, Kevin D.
New molecular targets in the treatment of rheumatoid arthritis.
Wallace, Beth I. a,b,c; Cooney, Laura a; Fox, David A. a
Describing calcium pyrophosphate deposition: undoing the tower of Babel!
Sirotti, Silvia a; Terkeltaub, Robert b; Filippou, Georgios a,c
